Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

April 2026

LSD

What April 2026's 8 new studies found, synthesized from the papers below. All LSD research →

The synthesis

Synthesized from 7 studies in the library · AI-generated, grounded in the abstracts below

Found by searching the library for LSD, lysergic acid diethylamide, lysergide, then ranked by relevance.

Research on LSD in April 2026 primarily consisted of reviews and commentaries, with no new clinical trials reported. The evidence suggests LSD has therapeutic potential for conditions like depression and fibromyalgia, but findings are based on historical data, animal models, and proposed mechanisms rather than recent human trials. A key caveat is the lack of empirical support for mechanisms like repressed memory recovery and the methodological challenges in psychedelic research.

Evidence by study

Direction is which way each study's own result points, not our rating of the study.

What the directions mean
Supports:
the study found the intervention worked, or its hypothesis held.
Opposes:
it found the opposite, no benefit or a harm.
No effect:
no significant difference either way.
Mixed:
effects in both directions within the same study.
Unclear:
the abstract does not report a direction.
Evaluating the evidence for repressed memory recovery in psychedelic contexts 2026
Unclear

The review found limited empirical support for mechanisms by which LSD might recover repressed memories.

scoping review Sample size: 53

Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers 2026
Supports

The commentary notes LSD's therapeutic promise in mental health treatment but emphasizes the need for rigorous validation.

commentary

A New Use for an Old Compound: Microdosing LSD to Reduce Fibromyalgia Symptoms 2026
Supports

Microdosed LSD improved pain-related behaviors in a sex- and route-dependent manner in a mouse model of fibromyalgia.

animal study

Dorsal Raphe Revisited: A Systems Neuroscience Lens on Psychedelic Drug Action 2026
Unclear

The review traces historical research on LSD's effects on the dorsal raphe, noting early hypotheses were later revised.

review

[LSD revisited: Mechanisms of action and therapeutic potential in mental health]. 2026
Supports

The review discusses LSD's potential for treatment-resistant depression via 5-HT2A receptor modulation and neuroplasticity, but notes methodological hurdles.

review

Psycholytic Therapy Using LSD: a Realist Review. 2026
Supports

The review found that psycholytic therapy with LSD showed potential to improve severe mental health conditions when specific therapeutic practices were followed.

realist review

Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action. 2026
Supports

The review supports LSD as a unified therapeutic approach for comorbid MDD and chronic pain through multiple proposed mechanisms.

narrative review

Points of agreement

  • Multiple reviews agree that LSD has therapeutic potential for mental health conditions like depression and chronic pain.
  • The proposed mechanisms often involve 5-HT2A receptor modulation and neuroplasticity.
  • All reviews note the need for more rigorous, ethically guided research.

Conflicts

  • The scoping review on repressed memory found limited empirical support for mechanisms, while other reviews are more optimistic about therapeutic mechanisms.
  • The animal study shows sex- and route-dependent effects, which may not generalize to human populations.

Gaps

  • No new human clinical trials on LSD were reported in the provided studies.
  • The durability of LSD's effects and long-term safety are not addressed.
  • Methodological challenges like placebo control and blinding remain unresolved.
  • Research on comorbid conditions (e.g., MDD and chronic pain) is largely unexplored.
Browse these studies in the library